Durable audit route for one claim-like target. This page shows source-use records, assessment rationale, active challenges, revisions, and graph edges tied to the same target identity.
insulin sensitivity enhancement is included with provisional confidence because the record has direct section evidence but still needs endpoint-specific interpretation before it should be read as a strong clinical claim.
The assessment is anchored to the cited practice effect record rather than inferred from the compound name alone.
Sources considered for this assessment[1]
The row has an explicit structured record and citation mapping.
The current seed evidence does not yet carry the same detailed endpoint interpretation as Taurine.
The audit path is present; additional source interpretation can be added without changing the schema.
Aerobic exercise is included as a glucose and insulin-sensitivity context, especially when baseline metabolic risk, adherence, and total weekly volume are considered.
This source is used to support the Insulin Sensitivity Enhancement effect row for this practice.